ID   YCUB-6
AC   CVCL_A087
SY   YCUB6; YcuB6; Yokohama City University BCP-ALL-6
DR   DSMZ; ACC-966
DR   Wikidata; Q54995379
RX   PubMed=19157546;
RX   PubMed=29786757;
RX   PubMed=32144432;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~3-4 days (DSMZ=ACC-966).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-966
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 20,24
ST   D3S1358: 12,17
ST   D5S818: 13,14
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 8,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=19157546; DOI=10.1016/j.leukres.2008.12.003;
RA   Goto H., Naruto T., Tanoshima R., Kato H., Yokosuka T.,
RA   Yanagimachi M., Fujii H., Yokota S., Komine H.;
RT   "Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic
RT   leukemia cell lines, YCUB series, derived from children.";
RL   Leuk. Res. 33:1386-1391(2009).
//
RX   PubMed=29786757; DOI=10.1007/s12185-018-2474-7;
RA   Tomoyasu C., Imamura T., Tomii T., Yano M., Asai D., Goto H.,
RA   Shimada A., Sanada M., Iwamoto S., Takita J., Minegishi M., Inukai T.,
RA   Sugita K., Hosoi H.;
RT   "Copy number abnormality of acute lymphoblastic leukemia cell lines
RT   based on their genetic subtypes.";
RL   Int. J. Hematol. 108:312-318(2018).
//
RX   PubMed=32144432; DOI=10.1007/s00280-020-04045-9;
RA   Goto H., Yoshino Y., Ito M., Nagai J.-i., Kumamoto T., Inukai T.,
RA   Sakurai Y., Miyagawa N., Keino D., Yokosuka T., Iwasaki F.,
RA   Hamanoue S., Shiomi M., Goto S.;
RT   "Aurora B kinase as a therapeutic target in acute lymphoblastic
RT   leukemia.";
RL   Cancer Chemother. Pharmacol. 85:773-783(2020).
//
RX   PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068;
RA   Tamai M., Kasai S., Akahane K., Thu T.N., Kagami K., Komatsu C.,
RA   Abe M., Watanabe A., Goi K., Miyake K., Inaba T., Takita J., Goto H.,
RA   Minegishi M., Iwamoto S., Sugita K., Inukai T.;
RT   "Glucocorticoid receptor gene mutations confer glucocorticoid
RT   resistance in B-cell precursor acute lymphoblastic leukemia.";
RL   J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022).
//